Interviews

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the growth of the annual NASP Specialty Pharmacy Conference, held from Sept. 29 through Oct. 1, 2015.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses the difficulties pharmacies face regarding clinical support for patients starting specialty therapies.

Nick Gentile, Director of State Grassroots Advocacy and Political Action for ASHP, discusses different legislative issues generating buzz on the state level, including biosimilars.

Joseph Morse, president and chief operating officer of Therigy, LLC, discusses significant challenges in over the next five years in specialty pharmacy.

Nick Gentile, Director of State Grassroots Advocacy and Political Action for ASHP, discusses the current status of provider status movements on the state level.

CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how accountable care organizations impact specialty pharmacy.

David Lassen, chief clinical officer at Prime Therapeutics, discusses the potential long term impact from biosimilars on the specialty drug landscape.

Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, talks about how health benefit design can increase smoking cessation.

Heather Bonome, PharmD, director of Pharmacy Segment at URAC, discusses the standards that illustrate quality in specialty pharmacy.

Kristen L. Marjama, DNP, MSN, FNP-BC, clinical educator with Healthcare Clinic at Walgreens in Fort Lauderdale, Florida, discusses the biggest roadblocks to managing asthma.

Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, discusses the advantages of community pharmacy-led smoking cessation programs versus other health providers' programs.

Kristen L. Marjama, DNP, MSN, FNP-BC, clinical educator with Healthcare Clinic at Walgreens in Fort Lauderdale, Florida, discusses counseling points for different asthma medication classes.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses changes ahead for specialty pharmacy patients.

Michael Zeglinski, Vice President of Specialty Pharmacy Operations at BriovaRx, discusses how health care reform has changed specialty pharmacy.

Kimberly Henderson, MD, JD, medical director for the Health Systems Alliance at CVS Health and regional medical director for MinuteClinic, discusses how MinuteClinic enhances COPD management.

Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, talks about how to prepare community pharmacists to provide both behavioral and pharmacotherapeutic smoking cessation advice.

Doug Long, vice president of industry relations at IMS Health, talks about trends pharmacists should look out for in the future.

Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research and associate professor at Wilkes University, discusses metrics in care transitions that pharmacists should pay attention to.

Paul Greenall, senior vice president of strategy and business development at McKesson Corporation, discusses how community pharmacies can build new networks of customers.

Doug Long, vice president of industry relations at IMS Health, talks about how the movement toward value-based care in the US health system affects community pharmacy.

Doug Long, vice president of industry relations at IMS Health, talks about which approved or pipeline drugs will be growth drivers in the industry during the next few years.

Bruce A. Berger, PhD, president of Berger Consulting LLC, discusses at what point in the continuum of patient care motivational interviewing is most successful and most critical.

Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, talks about gaps in pharmacy systems' support of smoking cessation.

Doug Long, vice president of industry relations at IMS Health, talks about how community pharmacies have been impacted by new trends in the industry.

Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses challenges associated with the integration of information technologies into pharmacy practice.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses how specialty pharmacies can best navigate complex reporting requirements from multiple entities.

Bruce A. Berger, PhD, president of Berger Consulting LLC, discusses how motivational interviewing plays into value-based care.

Doug Long, vice president of industry relations at IMS Health, discusses if health care providers will be hesitant to prescribe biosimilars.

Kimberly Henderson, MD, JD, medical director for the Health Systems Alliance at CVS Health and regional medical director for MinuteClinic, discusses the biggest roadblocks to managing COPD and how pharmacists can help overcome those challenges.

Doug Long, vice president of industry relations at IMS Health, talks about the most significant market trend in the pharmaceutical industry so far in 2015.